Mark M. Sieczkarek M.B.A.
|Age||Total Calculated Compensation||This person is connected to 56 board members in 2 different organizations across 4 different industries.|
See Board Relationships
Mr. Mark M. Sieczkarek, M.B.A. has been the Chief Executive Officer at NovaBay Pharmaceuticals, Inc. since June 3, 2016 and has been its President since June 13, 2016. Mr. Sieczkarek served as an Interim Chief Executive Officer and Interim President at NovaBay Pharmaceuticals, Inc since November 28, 2015 until June 3, 2016. Mr. Sieczkarek served as the Interim Chief Executive Officer and Interim President of Solta Medical, Inc., from August 23, 2013 to January 24, 2014. ...
25881 Industrial BoulevardPhone: 510-782-2286
Hayward, California 94545
Board Members Memberships*
Chairman, Chief Executive Officer and President
University at Buffalo
Annual Compensation*There is no Annual Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.